{"id":"https://openalex.org/W4362593280","doi":"https://doi.org/10.1158/1538-7445.am2023-4572","title":"Abstract 4572: 3D-EXpress ex vivo platform using a biorepository of characterized fresh patient tumoroids allows development of rational combinations with drugs targeting DNA damage response and immune checkpoint blockade","display_name":"Abstract 4572: 3D-EXpress ex vivo platform using a biorepository of characterized fresh patient tumoroids allows development of rational combinations with drugs targeting DNA damage response and immune checkpoint blockade","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362593280","doi":"https://doi.org/10.1158/1538-7445.am2023-4572"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2023-4572","doi":"https://doi.org/10.1158/1538-7445.am2023-4572","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4572","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042557844","display_name":"Jared C. Ehrhart","orcid":"https://orcid.org/0000-0003-0679-4684","observed_orcids":["https://orcid.org/0000-0003-0679-4684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jared Ehrhart","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058574624","display_name":"Seth Currlin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Currlin","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001295137","display_name":"Sharon Camacho","orcid":"https://orcid.org/0000-0003-2390-0880","observed_orcids":["https://orcid.org/0000-0003-2390-0880"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sharon Camacho","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Samantha Hoffman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha Hoffman","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020603475","display_name":"Angie Rivera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angie Rivera","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043205942","display_name":"Soner Altiok","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Soner Altiok","raw_affiliation_strings":["1Nilogen Oncosystems, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Nilogen Oncosystems, Tampa, FL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"83","issue":"7_Supplement","first_page":"4572","last_page":"4572"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9369999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.023499999195337296,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.007600000128149986,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9470000267028809},{"id":"https://openalex.org/keywords/dna-damage-response","display_name":"DNA damage response","score":0.8479999899864197},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9150000214576721},{"id":"https://openalex.org/keywords/wee1-inhibitor","display_name":"WEE1 inhibitor","score":0.828000009059906},{"id":"https://openalex.org/keywords/azd1775","display_name":"AZD1775","score":0.9359999895095825},{"id":"https://openalex.org/keywords/atr-inhibitors","display_name":"ATR inhibitors","score":0.9800000190734863},{"id":"https://openalex.org/keywords/azd6738","display_name":"AZD6738","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.8379999995231628},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6679999828338623},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hpv-status","display_name":"HPV status","score":0.5989999771118164},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.7649999856948853},{"id":"https://openalex.org/keywords/egfr-expression","display_name":"EGFR expression","score":0.8230000138282776},{"id":"https://openalex.org/keywords/drug-combination-therapy","display_name":"drug combination therapy","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8434156179428101},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5817363858222961},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5794478058815002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5421738028526306},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.510319173336029},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4848979115486145},{"id":"https://openalex.org/C2780932742","wikidata":"https://www.wikidata.org/wiki/Q4915239","display_name":"Biorepository","level":3,"score":0.47617262601852417},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.44818851351737976},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.42783206701278687},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.32658451795578003},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2639787197113037},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.18471506237983704},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C116567970","wikidata":"https://www.wikidata.org/wiki/Q864217","display_name":"Biobank","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2023-4572","doi":"https://doi.org/10.1158/1538-7445.am2023-4572","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2023-4572","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388072438","https://openalex.org/W4393071776","https://openalex.org/W4362594318","https://openalex.org/W4415899188","https://openalex.org/W4388047614","https://openalex.org/W4282975864","https://openalex.org/W4393096121","https://openalex.org/W4308375603","https://openalex.org/W3069276394","https://openalex.org/W4254912952"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Nilogen":[2],"Oncosystems\u2019":[3],"3D-EXpress":[4,55,306,380],"platform":[5,56,314,383],"allows":[6,392],"for":[7,16,51,153,157,188,208,219,297,360,414],"the":[8,112,122,239,298,356,364,411],"detailed":[9,141],"characterization":[10],"offreshly":[11],"resected":[12],"patient":[13,97,128,159,326,390],"tumor":[14,31,62,131,142,160,196,248,257,327],"tissue":[15],"inclusion":[17],"in":[18,74,85,121,150,179,226,324,363],"studies":[19],"investigating":[20,61],"rational":[21,395],"combinations":[22,323,396],"of":[23,300,319,339,387,394,410],"IOtherapeutics.":[24],"Incorporating":[25],"data":[26,209,346],"on":[27,275],"immune":[28,69,143,289,342,404],"cell":[29,32,63,197],"composition,":[30],"target":[33],"expression,":[34],"mutationalstatus,":[35],"and":[36,68,78,99,135,145,172,178,191,204,242,268,288,321,344,403,423],"HPV":[37,136,260],"infection":[38],"within":[39,246],"tumoroids":[40,81,118,156,216,391],"generated":[41,88],"from":[42,89,214],"HNSCC":[43],"tissues":[44,50],"provides":[45,311],"tremendous":[46],"input":[47],"toidentify":[48],"candidate":[49],"therapeutic":[52],"testing.":[53],"The":[54,116],"employed":[57],"here":[58],"providesdetailed":[59],"observations":[60],"viability":[64],"using":[65,384],"confocal":[66],"microscopy":[67],"cellactivation":[70],"indicated":[71],"by":[72,251,272],"increases":[73],"cytokine":[75,221],"release.":[76],"Materials":[77],"Methods:":[79],"3D":[80,201],"measuring":[82],"150":[83],"microns":[84],"size":[86],"were":[87,119,161,217,235],"fresh":[90,325,389],"patientHNSCC":[91],"resection":[92],"samples":[93,328],"collected":[94],"with":[95,167,181,238,329,337,397],"proper":[96],"consent":[98],"relevant":[100,352],"IRB":[101],"approval.":[102],"Tumoroidswere":[103],"never":[104],"enzymatically":[105],"dissociated,":[106],"propagated,":[107],"or":[108],"reassembled":[109],"to":[110,139,223,233,256,315,349,354],"maintain":[111],"intact":[113,330],"tumormicroenvironment":[114],"(TME).":[115],"resulting":[117],"cryopreserved":[120],"Biorepository,":[123],"where":[124],"eachsample":[125],"had":[126],"associated":[127,276],"demographic":[129],"data,":[130],"grade,":[132],"stage,":[133],"mutational":[134,258],"status":[137],"inaddition":[138,255],"a":[140,146,168,182,205,293,312,385],"profile":[144],"FFPE":[147],"representative":[148],"sample":[149],"TMA":[151,277],"format":[152],"targetselection.":[154],"Pooled":[155],"each":[158,247,340],"treated":[162,215],"ex":[163,229,307,381],"vivo":[164,230,308,334,382],"both":[165],"singly":[166],"selectiveWEE1":[169],"inhibitor,":[170],"AZD1775":[171],"an":[173],"ATR":[174],"blocker":[175],"AZD6738":[176],"alone":[177],"combination":[180,295],"PD-1":[183],"immunecheckpoint":[184],"inhibitor":[185],"antibody":[186],"nivolumab":[187],"72h.":[189],"Results":[190],"Summary:":[192],"To":[193],"quantify":[194],"treatment-mediated":[195],"killing":[198],"we":[199],"used":[200,218],"high-contentconfocal":[202],"imaging":[203],"proprietary":[206],"algorithm":[207],"analysis.":[210],"Additionally,":[211],"culture":[212],"supernatantsisolated":[213],"multiplex":[220,273],"detection":[222],"monitor":[224],"changes":[225],"theTME":[227],"upon":[228],"treatment.":[231],"Responses":[232],"treatments":[234],"further":[236],"correlated":[237],"composition":[240],"ofinnate":[241],"adaptive":[243],"TIL":[244],"populations":[245],"as":[249,264,266],"assessed":[250],"21-color":[252],"flow":[253],"cytometry":[254],"status,":[259,263],"infection,":[261],"smoking":[262],"well":[265],"EGFR":[267],"PD-L1expression":[269],"levels":[270],"analyzed":[271],"IF":[274],"slides.":[278],"Conclusion:":[279],"These":[280],"results":[281],"demonstrate":[282],"that":[283,304],"targeting":[284,399],"DNA":[285,400],"damage":[286,401],"response":[287,402],"checkpointblockade":[290],"may":[291,347],"provide":[292],"potential":[294],"strategy":[296],"treatment":[299],"HNSCC.":[301],"Furthermore,":[302],"weshowed":[303],"our":[305],"tumoroid":[309],"model":[310],"unique":[313],"rapidly":[316],"assess":[317],"theefficacy":[318],"drugs":[320,398],"drug":[322,335],"TME.":[331],"Correlation":[332],"ofex":[333],"responses":[336],"characteristics":[338],"tumor\u2019s":[341],"microenvironment":[343],"detailedclinicopathological":[345],"allow":[348],"identify":[350],"clinically":[351],"biomarkers":[353],"enable":[355],"most":[357],"effectivetreatment":[358],"strategies":[359],"individual":[361],"patients":[362],"clinic.":[365],"Citation":[366],"Format:":[367],"Jared":[368],"Ehrhart,":[369],"Seth":[370],"Currlin,":[371],"Sharon":[372],"Camacho,":[373],"Samantha":[374],"Hoffman,":[375],"Angie":[376],"Rivera,":[377],"Soner":[378],"Altiok.":[379],"biorepository":[386],"characterized":[388],"development":[393],"checkpoint":[405],"blockade.":[406],"[abstract].":[407],"In:":[408],"Proceedings":[409],"American":[412],"Association":[413],"Cancer":[415,434],"Research":[416],"Annual":[417],"Meeting":[418],"2023;":[419],"Part":[420],"1":[421],"(Regular":[422],"Invited":[424],"Abstracts);":[425],"2023":[426],"Apr":[427],"14-19;":[428],"Orlando,":[429],"FL.":[430],"Philadelphia":[431],"(PA):":[432],"AACR;":[433],"Res":[435],"2023;83(7_Suppl):Abstract":[436],"nr":[437],"4572.":[438]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-06T00:00:00"}
